Tranylcypromine: Difference between revisions
Created page with "{{intro}} Tranylcypromine is a nonhydrazine monamine oxidase inhibitor (MAO inhibitor) used in therapy of severe depression. {{livtox}} Tranylcypromine therapy is associ..." |
CSV import |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{ | {{Short description|A monoamine oxidase inhibitor used as an antidepressant}} | ||
Tranylcypromine | {{Drugbox | ||
| verifiedrevid = 477318123 | |||
| image = Tranylcypromine.svg | |||
| image2 = Tranylcypromine-MAO-inhibiton.png | |||
| image3 = Tranylcypromine-10mg-Quarter.jpg | |||
| image4 = Tranylcypromine-synth.png | |||
}} | |||
'''Tranylcypromine''' is a [[monoamine oxidase inhibitor]] (MAOI) used as an [[antidepressant]]. It is primarily used to treat [[major depressive disorder]] and is known for its effectiveness in patients who do not respond to other treatments. | |||
Tranylcypromine | |||
==Pharmacology== | |||
Tranylcypromine | Tranylcypromine works by inhibiting the activity of the enzyme [[monoamine oxidase]], which is responsible for breaking down [[neurotransmitters]] such as [[serotonin]], [[norepinephrine]], and [[dopamine]]. By inhibiting this enzyme, tranylcypromine increases the levels of these neurotransmitters in the brain, which can help alleviate symptoms of depression. | ||
==Medical uses== | |||
Tranylcypromine | Tranylcypromine is used in the treatment of major depressive disorder, particularly in cases where other antidepressants have failed. It is also sometimes used in the treatment of [[anxiety disorders]] and [[panic disorder]]. | ||
==Side effects== | |||
Common side effects of tranylcypromine include dizziness, dry mouth, insomnia, and headache. More serious side effects can include hypertensive crisis, especially when taken with certain foods or other medications that interact with MAOIs. | |||
==Interactions== | |||
Tranylcypromine can interact with a variety of substances, including certain foods and medications. Foods high in [[tyramine]], such as aged cheeses and cured meats, should be avoided as they can cause a dangerous increase in blood pressure. It is also important to avoid other medications that can interact with MAOIs, such as certain [[antidepressants]], [[sympathomimetics]], and [[opioids]]. | |||
==History== | |||
Tranylcypromine was first introduced in the 1960s as an antidepressant. It was one of the first MAOIs to be used clinically and has been used in the treatment of depression for several decades. | |||
{{ | ==Synthesis== | ||
The synthesis of tranylcypromine involves the cyclization of [[phenylalanine]] derivatives. The process results in the formation of a cyclopropylamine structure, which is crucial for its activity as an MAOI. | |||
==Related pages== | |||
* [[Monoamine oxidase inhibitor]] | |||
* [[Major depressive disorder]] | |||
* [[Antidepressant]] | |||
==References== | |||
{{Reflist}} | |||
[[Category:Antidepressants]] | |||
[[Category:Monoamine oxidase inhibitors]] | |||
[[Category:Phenethylamines]] | |||
== Tranylcypromine == | |||
<gallery> | |||
File:Tranylcypromine.svg|Chemical structure of Tranylcypromine | |||
File:Tranylcypromine-MAO-inhibiton.png|Mechanism of MAO inhibition by Tranylcypromine | |||
File:Tranylcypromine-10mg-Quarter.jpg|Tranylcypromine 10 mg tablet next to a quarter for scale | |||
File:Tranylcypromine-synth.png|Synthesis pathway of Tranylcypromine | |||
</gallery> | |||
Latest revision as of 03:46, 18 February 2025
A monoamine oxidase inhibitor used as an antidepressant
| Tranylcypromine | |
|---|---|
| |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Tranylcypromine is a monoamine oxidase inhibitor (MAOI) used as an antidepressant. It is primarily used to treat major depressive disorder and is known for its effectiveness in patients who do not respond to other treatments.
Pharmacology[edit]
Tranylcypromine works by inhibiting the activity of the enzyme monoamine oxidase, which is responsible for breaking down neurotransmitters such as serotonin, norepinephrine, and dopamine. By inhibiting this enzyme, tranylcypromine increases the levels of these neurotransmitters in the brain, which can help alleviate symptoms of depression.
Medical uses[edit]
Tranylcypromine is used in the treatment of major depressive disorder, particularly in cases where other antidepressants have failed. It is also sometimes used in the treatment of anxiety disorders and panic disorder.
Side effects[edit]
Common side effects of tranylcypromine include dizziness, dry mouth, insomnia, and headache. More serious side effects can include hypertensive crisis, especially when taken with certain foods or other medications that interact with MAOIs.
Interactions[edit]
Tranylcypromine can interact with a variety of substances, including certain foods and medications. Foods high in tyramine, such as aged cheeses and cured meats, should be avoided as they can cause a dangerous increase in blood pressure. It is also important to avoid other medications that can interact with MAOIs, such as certain antidepressants, sympathomimetics, and opioids.
History[edit]
Tranylcypromine was first introduced in the 1960s as an antidepressant. It was one of the first MAOIs to be used clinically and has been used in the treatment of depression for several decades.
Synthesis[edit]
The synthesis of tranylcypromine involves the cyclization of phenylalanine derivatives. The process results in the formation of a cyclopropylamine structure, which is crucial for its activity as an MAOI.
Related pages[edit]
References[edit]
<references group="" responsive="1"></references>
Tranylcypromine[edit]
-
Chemical structure of Tranylcypromine -
Mechanism of MAO inhibition by Tranylcypromine -
Tranylcypromine 10 mg tablet next to a quarter for scale -
Synthesis pathway of Tranylcypromine
